Daiwa Securities Group Inc. - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5
+25.0%
3410.0%0.00%
Q2 2023$4
+33.3%
3410.0%0.00%
Q1 2023$3
+50.0%
3410.0%0.00%
Q4 2022$2
-99.8%
341
+124.3%
0.00%
Q3 2022$1,0001520.0%0.00%
Q2 2022$01520.0%0.00%
Q1 2022$0
-100.0%
1520.0%0.00%
Q4 2021$1,0000.0%1520.0%0.00%
Q3 2021$1,0000.0%1520.0%0.00%
Q2 2021$1,0000.0%1520.0%0.00%
Q1 2021$1,0000.0%1520.0%0.00%
Q4 2020$1,000
-66.7%
152
-59.8%
0.00%
Q3 2020$3,000
+200.0%
3780.0%0.00%
Q2 2020$1,0000.0%3780.0%0.00%
Q1 2020$1,0000.0%3780.0%0.00%
Q4 2019$1,000
-50.0%
3780.0%0.00%
Q3 2019$2,000
-33.3%
3780.0%0.00%
Q2 2019$3,000
-40.0%
3780.0%0.00%
Q1 2019$5,000
-16.7%
378
-46.0%
0.00%
Q4 2018$6,0007000.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 2,023,369$27,154,0009.26%
Omega Fund Management, LLC 551,477$7,401,0005.46%
Foresite Capital Management III, LLC 1,562,040$20,963,0004.51%
Versant Venture Management, LLC 1,048,601$14,072,225,0004.39%
Boxer Capital, LLC 2,094,000$28,101,0003.18%
Opaleye Management Inc. 697,500$9,360,0002.42%
Abingworth LLP 273,417$3,667,0002.10%
DAFNA Capital Management LLC 294,511$3,952,0001.85%
NEXTHERA CAPITAL LP 828,655$11,121,0001.72%
Vivo Capital, LLC 906,000$12,158,0001.57%
View complete list of CYMABAY THERAPEUTICS INC shareholders